secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENET HEALTHCARE CORP (THC)
CIK:        0000070318
Form:       8-K
Filed at:   2021-09-03T23:59:59+00:00
Accession:  0001193125-21-265516
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenet Healthcare CEO transition: Rittenmeyer to Executive Chairman, Sutaria becomes CEO Sept 1, 2021
--------------------------------------------------------------------------------

- Ronald Rittenmeyer transitions from CEO to Executive Chairman through 2022, then advisor through 2024; base salary $1.5M then $750K, retention bonus $5M.
- Saumya Sutaria promoted to CEO effective Sept 1, 2021; base salary $1.2M, target bonus 125% of salary, equity award $8M in RSUs.
- Sutaria's employment agreement initial term through Dec 31, 2025, with automatic one-year renewals; severance provisions detailed.
- Rittenmeyer receives $5M retention bonus payable Dec 31, 2024 if employed through Term; accelerated vesting on qualifying termination.
- Both executives subject to perpetual confidentiality, non-disparagement, and post-employment non-compete/non-solicit covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70318/000119312521265516/0001193125-21-265516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70318/000119312521265516/d268536d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-265516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer